• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Differences in Cardiometabolic Comorbidities Between Black and White Persons Living With Multiple Sclerosis.黑人和白人多发性硬化症患者的心脏代谢合并症存在差异。
Arch Phys Med Rehabil. 2022 Feb;103(2):331-335. doi: 10.1016/j.apmr.2021.10.011. Epub 2021 Oct 30.
2
Characteristics Associated With Racial/Ethnic Disparities in COVID-19 Outcomes in an Academic Health Care System.在学术医疗体系中,与新冠疫情结果的种族/民族差异相关的特征。
JAMA Netw Open. 2020 Oct 1;3(10):e2025197. doi: 10.1001/jamanetworkopen.2020.25197.
3
Obesity is associated with race/sex disparities in diabetes and hypertension prevalence, but not cardiovascular disease, among HIV-infected adults.在感染艾滋病毒的成年人中,肥胖与糖尿病和高血压患病率方面的种族/性别差异相关,但与心血管疾病无关。
AIDS Res Hum Retroviruses. 2015 Sep;31(9):898-904. doi: 10.1089/AID.2015.0062. Epub 2015 Jul 23.
4
Association between cardiometabolic risk factors and body mass index based on diagnosis and treatment codes in an electronic medical record database.基于电子病历数据库中的诊断和治疗编码,心血管代谢危险因素与体重指数之间的关联。
J Manag Care Pharm. 2008 Oct;14(8):756-67. doi: 10.18553/jmcp.2008.14.8.756.
5
Characterizing relapsing remitting multiple sclerosis patients burdened with hypertension, hyperlipidemia, and asthma.描述伴有高血压、高血脂和哮喘的复发缓解型多发性硬化症患者的负担。
Mult Scler Relat Disord. 2021 Aug;53:103040. doi: 10.1016/j.msard.2021.103040. Epub 2021 May 21.
6
Combined associations of 25-hydroxivitamin D and parathyroid hormone with diabetes risk and associated comorbidities among U.S. white and black women.美国白人和黑人女性中 25-羟维生素 D 和甲状旁腺激素与糖尿病风险及其相关合并症的联合关联。
Nutr Diabetes. 2021 Sep 16;11(1):29. doi: 10.1038/s41387-021-00171-2.
7
Management of diabetes and hypertension in people with multiple sclerosis.多发性硬化症患者的糖尿病和高血压管理。
Mult Scler Relat Disord. 2020 May;40:101987. doi: 10.1016/j.msard.2020.101987. Epub 2020 Feb 8.
8
Racial disparities in hypertension management among multiple sclerosis patients.多发性硬化症患者高血压管理中的种族差异。
Mult Scler Relat Disord. 2022 Aug;64:103972. doi: 10.1016/j.msard.2022.103972. Epub 2022 Jun 15.
9
Descriptive Analysis of Health Disparities Between Black and White People With Multiple Sclerosis in the Deep South.美国最南部地区黑人和白人多发性硬化症患者健康差异的描述性分析。
Int J MS Care. 2024 Jul 1;26(Q3):167-173. doi: 10.7224/1537-2073.2023-084. eCollection 2024 May.
10
Racial differences in weight perception among Black and White women diagnosed with breast cancer.黑人和白人女性乳腺癌患者体重感知的种族差异。
J Cancer Surviv. 2024 Apr;18(2):531-540. doi: 10.1007/s11764-022-01255-3. Epub 2022 Sep 28.

引用本文的文献

1
Multiple Sclerosis in People of Diverse Racial and Ethnic Backgrounds: Presentation, Disease Course, and Interactions with Disease-Modifying Therapy.不同种族和族裔背景人群中的多发性硬化症:临床表现、疾病进程以及与疾病修正治疗的相互作用
CNS Drugs. 2025 Jul 18. doi: 10.1007/s40263-025-01205-4.
2
Descriptive Analysis of Health Disparities Between Black and White People With Multiple Sclerosis in the Deep South.美国最南部地区黑人和白人多发性硬化症患者健康差异的描述性分析。
Int J MS Care. 2024 Jul 1;26(Q3):167-173. doi: 10.7224/1537-2073.2023-084. eCollection 2024 May.

本文引用的文献

1
Race and ethnicity on MS presentation and disease course.多发性硬化症发病表现和疾病进程中的种族和民族差异。
Mult Scler. 2020 Apr;26(5):561-567. doi: 10.1177/1352458519887328. Epub 2020 Jan 22.
2
Clinical Characteristics of Multiple Sclerosis in African-Americans.非裔美国人多发性硬化症的临床特征。
Curr Neurol Neurosci Rep. 2019 Nov 13;19(11):87. doi: 10.1007/s11910-019-1000-5.
3
The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United States.生活在美国的西班牙裔和非裔美国人多发性硬化症风险的遗传多样性。
Mult Scler. 2020 Oct;26(11):1329-1339. doi: 10.1177/1352458519863764. Epub 2019 Aug 1.
4
Measures of general and abdominal obesity and disability severity in a large population of people with multiple sclerosis.对大量多发性硬化症患者群体的全身和腹部肥胖及残疾严重程度的测量。
Mult Scler. 2020 Jul;26(8):976-986. doi: 10.1177/1352458519845836. Epub 2019 May 13.
5
The prevalence of MS in the United States: A population-based estimate using health claims data.美国多发性硬化症的患病率:基于健康索赔数据的人群估计。
Neurology. 2019 Mar 5;92(10):e1029-e1040. doi: 10.1212/WNL.0000000000007035. Epub 2019 Feb 15.
6
Brain and retinal atrophy in African-Americans versus Caucasian-Americans with multiple sclerosis: a longitudinal study.非裔美国人和白种人美国人多发性硬化症的脑和视网膜萎缩:一项纵向研究。
Brain. 2018 Nov 1;141(11):3115-3129. doi: 10.1093/brain/awy245.
7
Multiple Sclerosis Mortality by Race/Ethnicity, Age, Sex, and Time Period in the United States, 1999-2015.美国 1999-2015 年按种族/民族、年龄、性别和时间段划分的多发性硬化症死亡率。
Neuroepidemiology. 2018;50(1-2):35-40. doi: 10.1159/000484213. Epub 2018 Jan 16.
8
Ethnic Considerations and Multiple Sclerosis Disease Variability in the United States.美国的种族因素与多发性硬化症的疾病变异性
Neurol Clin. 2018 Feb;36(1):151-162. doi: 10.1016/j.ncl.2017.08.007.
9
Culturally Targeted Strategies for Diabetes Prevention in Minority Population.针对少数族裔人群预防糖尿病的文化针对性策略。
Diabetes Educ. 2017 Feb;43(1):54-77. doi: 10.1177/0145721716683811.
10
Hispanic Americans and African Americans with multiple sclerosis have more severe disease course than Caucasian Americans.西班牙裔美国人和非裔美国人多发性硬化症的疾病进程比白种人更为严重。
Mult Scler. 2017 Oct;23(11):1554-1557. doi: 10.1177/1352458516679894. Epub 2016 Nov 29.

黑人和白人多发性硬化症患者的心脏代谢合并症存在差异。

Differences in Cardiometabolic Comorbidities Between Black and White Persons Living With Multiple Sclerosis.

机构信息

Department of Occupational Therapy, School of Health Professions, University of Alabama at Birmingham, Birmingham, Alabama.

School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.

出版信息

Arch Phys Med Rehabil. 2022 Feb;103(2):331-335. doi: 10.1016/j.apmr.2021.10.011. Epub 2021 Oct 30.

DOI:10.1016/j.apmr.2021.10.011
PMID:34728190
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9808816/
Abstract

OBJECTIVE

To determine differences in obesity, type 2 diabetes, and hypertension in Black patients compared with White patients with multiple sclerosis (MS).

DESIGN

Cross-sectional database review.

SETTING

Large academic medical center research records database.

PARTICIPANTS

A total of 3191 patient cases (N=3191; 77% female, 34% Black) identified by MS diagnosis within the medical record.

INTERVENTIONS

Not applicable.

MAIN OUTCOME MEASURES

Diagnosis codes for type 2 diabetes and hypertension. Body mass index (BMI), race, age, and sex were collected. Analysis of variance (continuous variables) and chi-square analyses (categorical variables) were conducted to determine differences in obesity, diabetes, and hypertension between race and sex. Logistic regression was conducted to determine odds ratios (ORs) of developing diabetes and hypertension based on race, sex, BMI, and age.

RESULTS

Black patients were more than twice as likely to be diagnosed as having diabetes (OR, 2.15 [95% CI, 1.70-2.72]; P<.0001) or hypertension (OR, 2.44 [95% CI, 2.05-2.91], P<.0001) compared with White patients. Sex did not present a greater likelihood of being diagnosed as having diabetes; however, men were 1.22 times more likely be diagnosed as having hypertension compared with women (95% CI, 1.01-1.49; P=.0439). Increased age and BMI were also significantly associated with likelihood of diagnosis of diabetes and hypertension (age: diabetes OR, 1.05 [95% CI, 1.04-1.06], P<.0001; hypertension OR, 1.06 [95% CI, 1.05-1.06], P<.0001; BMI: diabetes obese vs normal: OR, 2.11 [95% CI, 1.43-3.11], P=.0002; hypertension: obese vs normal: OR, 1.72 [95% CI, 1.39-2.13], P<.0001).

CONCLUSIONS

Black patients with MS are significantly more likely to have cardiometabolic conditions than White patients. These conditions have been associated with poorer health outcomes for people with MS and may have some effect on the differences in MS disease course reported in Black patients.

摘要

目的

比较多发性硬化症(MS)黑人患者与白人患者的肥胖、2 型糖尿病和高血压差异。

设计

横断面数据库回顾。

地点

大型学术医疗中心研究记录数据库。

参与者

通过病历中 MS 诊断共确定 3191 例患者病例(N=3191;77%女性,34%黑人)。

干预措施

不适用。

主要观察指标

2 型糖尿病和高血压诊断代码。收集体重指数(BMI)、种族、年龄和性别。采用方差分析(连续变量)和卡方分析(分类变量)比较不同种族和性别的肥胖、糖尿病和高血压差异。采用 logistic 回归分析根据种族、性别、BMI 和年龄确定患糖尿病和高血压的优势比(OR)。

结果

黑人患者被诊断患有糖尿病(OR,2.15 [95%CI,1.70-2.72];P<.0001)或高血压(OR,2.44 [95%CI,2.05-2.91],P<.0001)的可能性是白人患者的两倍多。性别并不能增加被诊断患有糖尿病的可能性;然而,与女性相比,男性患高血压的可能性高 1.22 倍(95%CI,1.01-1.49;P=.0439)。年龄和 BMI 增加也与糖尿病和高血压的诊断可能性显著相关(年龄:糖尿病 OR,1.05 [95%CI,1.04-1.06],P<.0001;高血压 OR,1.06 [95%CI,1.05-1.06],P<.0001;BMI:糖尿病肥胖与正常:OR,2.11 [95%CI,1.43-3.11],P=.0002;高血压:肥胖与正常:OR,1.72 [95%CI,1.39-2.13],P<.0001)。

结论

多发性硬化症的黑人患者比白人患者更有可能出现心血管代谢疾病。这些情况与多发性硬化症患者的健康状况较差有关,并且可能对黑人群体报告的多发性硬化症病程差异有一定影响。